|
FY2026
12 months to Sep 3, 2026
|
FY2025
12 months to Aug 28, 2025
|
FY2024
12 months to Aug 29, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Sep 1, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross margin | |||||
| Research and development | |||||
| Selling, general, and administrative | |||||
| Restructure and asset impairments | |||||
| Other operating (income) expense, net | |||||
| Operating income | |||||
| Interest income | |||||
| Interest expense | |||||
| Other non-operating income (expense), net | |||||
| Income before income taxes and equity in net income (loss) of equity method investees | |||||
| Income tax (provision) benefit | |||||
| Equity in net income (loss) of equity method investees | |||||
| Net income | |||||
| Other comprehensive income (loss), net of tax | |||||
| Total comprehensive income | |||||
| Earnings per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Number of shares used in per share calculations | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
